GPR17
Basic information
Region (hg38): 2:127645864-127652639
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 2 |
Variants in GPR17
This is a list of pathogenic ClinVar variants found in the GPR17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-127650718-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
2-127650755-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
2-127650815-C-T | Benign (Jul 13, 2018) | |||
2-127650830-T-A | not specified | Uncertain significance (Jul 09, 2021) | ||
2-127650914-A-T | not specified | Uncertain significance (Dec 20, 2021) | ||
2-127651049-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
2-127651084-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
2-127651093-T-C | not specified | Uncertain significance (Nov 09, 2023) | ||
2-127651121-G-A | not specified | Uncertain significance (Aug 11, 2021) | ||
2-127651176-C-T | Likely benign (Jul 31, 2018) | |||
2-127651226-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
2-127651229-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
2-127651269-G-A | Benign (Jul 13, 2018) | |||
2-127651292-G-A | not specified | Uncertain significance (May 11, 2022) | ||
2-127651360-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
2-127651385-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
2-127651413-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
2-127651418-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
2-127651480-G-A | not specified | Uncertain significance (Mar 14, 2024) | ||
2-127651492-G-A | not specified | Uncertain significance (May 01, 2022) | ||
2-127651499-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
2-127651510-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
2-127651522-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
2-127651552-C-T | not specified | Uncertain significance (Apr 04, 2024) | ||
2-127651654-G-A | not specified | Uncertain significance (Mar 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR17 | protein_coding | protein_coding | ENST00000544369 | 2 | 6775 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000843 | 0.554 | 125702 | 0 | 41 | 125743 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0811 | 224 | 227 | 0.985 | 0.0000161 | 2357 |
Missense in Polyphen | 76 | 85.561 | 0.88826 | 870 | ||
Synonymous | -0.646 | 112 | 104 | 1.08 | 0.00000769 | 808 |
Loss of Function | 0.593 | 7 | 8.91 | 0.786 | 4.75e-7 | 92 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000819 | 0.000818 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Dual specificity receptor for uracil nucleotides and cysteinyl leukotrienes (CysLTs). Signals through G(i) and inhibition of adenylyl cyclase. May mediate brain damage by nucleotides and CysLTs following ischemia. {ECO:0000269|PubMed:16990797}.;
- Pathway
- GPCRs, Other;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;P2Y receptors;Eicosanoid ligand-binding receptors;Nucleotide-like (purinergic) receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;Leukotriene receptors;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.506
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.49
Haploinsufficiency Scores
- pHI
- 0.213
- hipred
- N
- hipred_score
- 0.204
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.150
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr17
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of inflammatory response to antigenic stimulus;G protein-coupled receptor signaling pathway;positive regulation of Rho protein signal transduction;oligodendrocyte differentiation;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;chemokine-mediated signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;chemokine receptor activity;receptor serine/threonine kinase binding